Bausch + Lomb (NYSE:BLCO) Update / briefing March 23, 2026 01:30 PM ET Company ParticipantsBrent Saunders - Chairman and CEOCathleen McCabe - Strategic Medical AdvisorKelly Swaim - SVP of Surgical R&DMayssa Attar - SVP of Pharmaceuticals and Consumer R&DYehia Hashad - EVP of R&D and Chief Medical OfficerConference Call ParticipantsLarry Biegelsen - Medical Device AnalystLarry BiegelsenGood afternoon. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. Welcome to the next call in our 2026 MedTech ...